Non-Hodgkin’s Lymphoma

Non-Hodgkin’s lymphoma (NHL) is a type of cancer that originates in the lymphatic system, an important part of the body's immune defense network. The disease develops when lymphocytes, a type of white blood cell, grow and multiply abnormally, forming tumors within lymph nodes and other tissues. Non-Hodgkin’s lymphoma encompasses a diverse group of lymphatic cancers that vary in behavior, severity, and treatment approaches. At Park Hospitals, advanced hematology and oncology services, specialized diagnostic facilities, and comprehensive cancer care programs support the early diagnosis and effective treatment of non-Hodgkin’s lymphoma to improve patient outcomes and quality of life.

The exact cause of non-Hodgkin’s lymphoma is not always known, but several factors may increase the risk of developing the condition. These include a weakened immune system, certain viral infections, autoimmune disorders, exposure to specific chemicals, increasing age, and a family history of lymphatic cancers. Most cases occur without a clearly identifiable cause.

Symptoms may vary depending on the type and extent of the disease. Common signs include painless swelling of lymph nodes in the neck, armpits, or groin, persistent fatigue, unexplained weight loss, fever, night sweats, itching, shortness of breath, and abdominal discomfort. Some individuals may not experience noticeable symptoms during the early stages.

If left untreated, non-Hodgkin’s lymphoma can spread to other lymph nodes, bone marrow, spleen, liver, and other organs. Advanced disease may impair immune function and lead to serious health complications.

Diagnosis typically involves a detailed medical evaluation along with lymph node biopsy, blood tests, bone marrow examination, CT scans, PET scans, MRI, and specialized laboratory investigations. These assessments help determine the specific subtype and stage of the lymphoma.

Treatment depends on the type, stage, and aggressiveness of the disease. Management may include chemotherapy, immunotherapy, targeted therapy, radiation therapy, stem cell transplantation, or a combination of treatment approaches tailored to individual needs.

With experienced hematologists, oncologists, advanced diagnostic technology, and multidisciplinary cancer care services, Park Hospitals provides personalized treatment and long-term support for individuals diagnosed with non-Hodgkin’s lymphoma. Early diagnosis and timely intervention can help improve treatment effectiveness, reduce complications, and support better long-term health outcomes.